Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

 
DONTNOD ENTERTAINMENT : TWIN MIRROR(TM): THE PSYCHOLOGICAL THRILLER SELF-PUBLISHED BY DONTNOD IS AVAILABLE ON STEAM
DONTNOD ENTERTAINMENT : TWIN MIRROR(TM): THE PSYCHOLOGICAL THRILLER SELF-PUBLISHED BY DONTNOD IS AVAILABLE ON STEAM

Paris, December 1st, 2021 – DONTNOD Entertainment, an independent French studio that creates, develops and publishes video games, is excited to announce the Steam release of its psychological

 
ACCOR ACQUISITION COMPANY S.A. : AAC - Number of shares and voting rights - 30112021
ACCOR ACQUISITION COMPANY S.A. : AAC - Number of shares and voting rights - 30112021

Regulated information

December 1, 2021

Declaration pursuant to article 223-16 of the General Regulations of the French Financial Markets Authority (Autorité des Marchés Financiers)

Date
Energie ist die Grundlage des Fortschritts
Energie ist die Grundlage des Fortschritts
Strom aus der Steckdose – für viele ist es zu einfach. Atomenergie gehört auf jeden Fall dazu, dass der Strom in die Steckdose kommt.   Eine kleine Rechnung, die jüngst bei Sprott Asset Management
Sinn über den Unsinn der Notenbanken-Politik
Sinn über den Unsinn der Notenbanken-Politik
Die Inflation ist kein Gespenst mehr. Um der Geldentwertung entgegenzutreten, hilft vor allem ein Investment in Gold und Goldaktien.   “Die Inflationsbremse ist blockiert”, schreibt Hans-Werner
Millionen Elektroautos werden Rohstoffe verschlingen
Millionen Elektroautos werden Rohstoffe verschlingen
Die künftige Koalition in Deutschland will Deutschland zum „Leitmarkt für E-Mobilität“ machen.   Rund 15 Millionen Elektroautos sollen bis zum Jahr 2030 die deutschen Straßen bevölkern. Der Boom
Auch Kupfer ist von Lieferkettenproblemen betroffen
Auch Kupfer ist von Lieferkettenproblemen betroffen
Lieferkettenprobleme ziehen sich durch die Rohstoffwelt. Kupfer ist da keine Ausnahme.   Im Jahr 2008 erlebte Kupfer eine Rezession. Dann stieg der Preis rasant an, Rekordpreise waren zu
KURSZIEL-HAMMER BEI 6 CAD! Quantensprünge und NEGATIVE CO2-Bilanz! Eine einmalige Investment-Chance!
KURSZIEL-HAMMER BEI 6 CAD! Quantensprünge und NEGATIVE CO2-Bilanz! Eine einmalige Investment-Chance!
Die renommierte Macquarie-Bank geht von einem Nickel-Defizit von etwa 100.000 Tonnen aus. Der Grund - niedrigere Minenproduktionen und höhere Nachfrage aus China!  ​​​​​​​   MEGA-TREND-E-Mobilität
Nutrien Announces Pedro Farah as a Speaker at the Scotiabank Mining Virtual Conference: https://mms.businesswire.com/media/20191104006030/en/699432/5/Nutrien_logo.jpg
Nutrien Announces Pedro Farah as a Speaker at the Scotiabank Mining Virtual Conference


Nutrien Ltd. (TSX and NYSE: NTR) announced today that Mr. Pedro Farah, Nutrien’s Executive Vice President and Chief Financial Officer, will be speaking at the Scotiabank Mining Virtual Conference

AgeX Therapeutics Receives Stock Exchange Deficiency Letter: https://mms.businesswire.com/media/20191108005662/en/711989/5/AGEX_High_Resolution_300dpi.jpg
AgeX Therapeutics Receives Stock Exchange Deficiency Letter


AgeX Therapeutics , Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on November 17, 2021 it received a

Exscientia gibt Redner für die 4. virtuelle Jahreskonferenz HealthCONx von Evercore ISI bekannt: https://mms.businesswire.com/media/20211110005488/en/925458/5/5299324_5299274_exscientia-logo.jpg
Exscientia gibt Redner für die 4. virtuelle Jahreskonferenz HealthCONx von Evercore ISI bekannt


Wie Exscientia (Nasdaq: EXAI) heute mitteilte, werden Andrew Hopkins, DPhil., Gründer und CEO von Exscientia, Ben Taylor, CFO und Chief Strategy Officer, und Garry Pairaudeau, Chief Technology

Exscientia to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference: https://mms.businesswire.com/media/20211110005488/en/925458/5/5299324_5299274_exscientia-logo.jpg
Exscientia to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference


Exscientia (Nasdaq: EXAI) today announced that Andrew Hopkins, DPhil., Exscientia’s founder and CEO, Ben Taylor, CFO & Chief Strategy Officer, and Garry Pairaudeau, Chief Technology Officer, will

Cortexyme to Present at 4th Annual Evercore ISI HealthCONx Conference on November 30th: https://mms.businesswire.com/media/20210504005295/en/1091862/5/logo_large_jpg.jpg
Cortexyme to Present at 4th Annual Evercore ISI HealthCONx Conference on November 30th


Cortexyme, Inc. (Nasdaq: CRTX) announced that Casey Lynch, chief executive officer, co-founder, and chair, will participate in a fireside chat at the 4th Annual Evercore ISI HealthCONx Conference

Elastic Joins AWS ISV Workload Migration Program and Integrates with AWS FireLens: https://mms.businesswire.com/media/20210324005957/en/712541/5/elastic-logo-V-full_color.jpg
Elastic Joins AWS ISV Workload Migration Program and Integrates with AWS FireLens


Elastic (NYSE: ESTC) (“Elastic”), the company behind Elasticsearch and the Elastic Stack, today announced that it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Workload

MedMen Prevails in Lawsuit Against Former CFO James Parker: https://mms.businesswire.com/media/20191111005149/en/659546/5/Medmen.LogoHorizontalRed.Reg.jpg
MedMen Prevails in Lawsuit Against Former CFO James Parker


MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today announced the company has prevailed in a

Nykode Therapeutics (Formerly Vaccibody*)) Enters Into Multi-target License and Collaboration Agreement With Regeneron to Develop Innovative Vaccines Against Cancer and Infectious Diseases
Nykode Therapeutics (Formerly Vaccibody*)) Enters Into Multi-target License and Collaboration Agreement With Regeneron to Develop Innovative Vaccines Against Cancer and Infectious Diseases


Nykode Therapeutics (formerly Vaccibody*)) (Euronext Growth (Oslo): VACC), a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel

Vaccibody Becomes Nykode Therapeutics - a New Name and Identity to Signify a New Phase of Growth and Development
Vaccibody Becomes Nykode Therapeutics - a New Name and Identity to Signify a New Phase of Growth and Development


Nykode Therapeutics (formerly Vaccibody*)) (Euronext Growth (Oslo): VACC (ticker will soon be changed)), a clinical-stage biopharmaceutical company dedicated to the discovery and development of

CURO to Participate in Upcoming Investor Conferences: https://mms.businesswire.com/media/20191216005180/en/763172/5/CGHC.jpg
CURO to Participate in Upcoming Investor Conferences


CURO Group Holdings Corp. (NYSE: CURO) (“CURO”), a tech-enabled, omni-channel consumer finance company serving non-prime and prime consumers in the U.S. and Canada, today announced that members of

Emerald Holding, Inc. to Present at the BofA Securities 2021 Virtual Leveraged Finance Conference
Emerald Holding, Inc. to Present at the BofA Securities 2021 Virtual Leveraged Finance Conference


Emerald Holding, Inc. (NYSE:EEX) (“Emerald” or the “Company”), today announced that Hervé Sedky, President and Chief Executive Officer, and David Doft, Chief Financial Officer, are scheduled to

MedMen Announces Michael Serruya as Chairman and Interim CEO: https://mms.businesswire.com/media/20191111005149/en/659546/5/Medmen.LogoHorizontalRed.Reg.jpg
MedMen Announces Michael Serruya as Chairman and Interim CEO


MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today announced its Board of Directors has

Real Matters Announces Amendment to Normal Course Issuer Bid: https://mms.businesswire.com/media/20191121005199/en/554103/5/RM_high_res_logo.jpg
Real Matters Announces Amendment to Normal Course Issuer Bid


Real Matters Inc. (“Real Matters” or the “Company”) (TSX: REAL) today announced that the Toronto Stock Exchange (“TSX”) has approved an amendment to the Company’s current Normal Course Issuer Bid

NOXXON: New Phase 1/2 Data On NOX-A12 & Radiotherapy Combination in Brain Cancer Presented at the Society for Neuro-Oncology Annual Meeting 2021
NOXXON: New Phase 1/2 Data On NOX-A12 & Radiotherapy Combination in Brain Cancer Presented at the Society for Neuro-Oncology Annual Meeting 2021


Regulatory News:



NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME)

NOXXON: PRÄSENTATION VON NEUEN DATEN DER PHASE-1/2-STUDIE MIT NOX-A12 IN KOMBINATION MIT STRAHLENTHERAPIE BEI PATIENTEN MIT GEHIRNTUMOREN ANLÄSSLICH DER JAHRESTAGUNG 2021 DER SOCIETY FOR NEURO-ONCOLOGY
NOXXON: PRÄSENTATION VON NEUEN DATEN DER PHASE-1/2-STUDIE MIT NOX-A12 IN KOMBINATION MIT STRAHLENTHERAPIE BEI PATIENTEN MIT GEHIRNTUMOREN ANLÄSSLICH DER JAHRESTAGUNG 2021 DER SOCIETY FOR NEURO-ONCOLOGY


NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), ein Biotechnologieunternehmen mit Fokus auf der Verbesserung von Krebstherapien durch gezielte Einwirkung auf die Tumormikroumgebung (TME), gibt

Technip Energies Partners with Svante to Develop Industrial-Scale Carbon Capture Projects in Europe and Middle-East: https://mms.businesswire.com/media/20210325005821/en/867429/5/TECHNIP_ENERGIES_LOGO_HORIZONTAL_RVB.jpg
Technip Energies Partners with Svante to Develop Industrial-Scale Carbon Capture Projects in Europe and Middle-East


Regulatory News:



Technip Energies (PARIS:TE) (ISIN:NL0014559478) and Svante have entered into a Memorandum of Understanding (MoU) to further develop Svante’s solid sorbent carbon capture

Strong Growth Continues at Naspers, on Top of Increased Scale
Strong Growth Continues at Naspers, on Top of Increased Scale


Naspers Limited (JSE: NPN) delivered a strong performance in the six months ending 30 September 2021, growing ecommerce revenues 52%. The group stepped up investment to further accelerate growth

Physisches Defizit bei Silber erwartet
Physisches Defizit bei Silber erwartet
Das renommierte Silver Institute lässt aufhorchen. Silber ist extrem gefragt.   Laut der Prognose des Instituts wird das laufende Jahr mit einem Höchststand der industriellen Silbernachfrage enden.